DR. CHRISTOS SOCRATES MANTZOROS, MD
Osteopathic Medicine in Boston, MA
License number
Massachusetts 77441
Category
Osteopathic Medicine
Type
Endocrinology, Diabetes & Metabolism
Address
Address
2
330 Brookline Ave St, Boston, MA 02215
151 Coolodge Ave #702, Watertown, MA 02472
151 Coolodge Ave #702, Watertown, MA 02472
Phone
(617) 667-8633
(617) 667-8634 (Fax)
(617) 667-8634 (Fax)
Personal information
See more information about CHRISTOS SOCRATES MANTZOROS at radaris.comName
Address
Phone
151 Coolidge Ave APT 702, Watertown, MA 02472
151 Coolidge Ave, Watertown, MA 02472
Professional information
See more information about CHRISTOS SOCRATES MANTZOROS at trustoria.com
Christos Socrates Mantzoros, Boston MA
Christos Socrates Mantzoros, Boston MA
Specialties:
Internist
Address:
330 Brookline Ave, Boston, MA 02215
Education:
Harvard University - Master of Science in Electrical Engineering
National and Kapodistrian University of Athens - Doctor of Science
University of Athens, School of Health Sciences - Doctor of Medicine
National and Kapodistrian University of Athens - Doctor of Science
University of Athens, School of Health Sciences - Doctor of Medicine
Board certifications:
American Board of Internal Medicine Sub-certificate in Endocrinology, Diabetes, and Metabolism (Internal Medicine)
Christos Mantzoros, Boston MA
Christos Mantzoros, Boston MA
Specialties:
Internal Medicine, Endocrinology, Diabetes & Metabolism, Endocrinology and Metabolism
Work:
Beth Israel Deaconess Medical Center
330 Brookline Ave, Boston, MA 02215
330 Brookline Ave, Boston, MA 02215
Education:
University Of Athens (1987)
Dr. Christos S Mantzoros, Boston MA - MD (Doctor of Medicine)
Dr. Christos S Mantzoros, Boston MA - MD (Doctor of Medicine)
Specialties:
Endocrinology, Diabetes & Metabolism
Address:
99 Brookline Ave SUITE 816, Boston 02215
(617) 632-8878 (Phone), (617) 667-2927 (Fax)
4201 Saint Antoine St SUITE 9C, Detroit 48201
(617) 632-8878 (Phone), (617) 667-2927 (Fax)
4201 Saint Antoine St SUITE 9C, Detroit 48201
Certifications:
Diabetes, Metabolism & Endocrinology, 2009, Internal Medicine, 1995
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
99 Brookline Ave SUITE 816, Boston 02215
4201 Saint Antoine St SUITE 9C, Detroit 48201
Beth Israel Deaconess Medical Center
330 Brookline Ave, Boston 02215
4201 Saint Antoine St SUITE 9C, Detroit 48201
Beth Israel Deaconess Medical Center
330 Brookline Ave, Boston 02215
Education:
Medical School
University of Athens / College of Medicine / School of Health Science National & Kapodistrian
Wayne State University
Harvard Medical School
University of Athens / College of Medicine / School of Health Science National & Kapodistrian
Wayne State University
Harvard Medical School
Use Of Adiponectin To Diagnose And Treat Malignancy
Use Of Adiponectin To Diagnose And Treat Malignancy
US Patent:
2005005, Mar 17, 2005
Filed:
Jul 20, 2004
Appl. No.:
10/895621
Inventors:
Christos Mantzoros - Watertown MA, US
Assignee:
Beth Israel Deaconess Medical Center, Inc. - Boston MA
International Classification:
A61K038/17, A61K031/4439, A61K031/426
US Classification:
514008000, 514340000, 514369000
Abstract:
Methods aiding in the diagnosis of endometrial cancer or a risk of endometrial cancer are disclosed, in which the level of adiponectin is assessed in a test sample. Methods aiding in the diagnosis of an epithelial cancer or a risk of an epithelial cancer are also disclosed, in which the level of adiponectin is assessed in a test sample. Representative epithelilal cancers include breast cancer, ovarian cancer, prostate cancer, leukemia and colon cancer. Also disclosed are methods of treating endometrial cancer or other epithelial cancers, comprising administering an adiponectin therapeutic agent.
Use Of Adiponectin To Diagnose And Treat Malignancy
Use Of Adiponectin To Diagnose And Treat Malignancy
US Patent:
2007012, May 31, 2007
Filed:
Dec 18, 2006
Appl. No.:
11/640649
Inventors:
Christos Mantzoros - Watertown MA, US
International Classification:
A61K 38/18
US Classification:
514008000
Abstract:
Methods aiding in the diagnosis of endometrial cancer or a risk of endometrial cancer are disclosed, in which the level of adiponectin is assessed in a test sample. Methods aiding in the diagnosis of an epithelial cancer or a risk of an epithelial cancer are also disclosed, in which the level of adiponectin is assessed in a test sample. Representative epithelilal cancers include breast cancer, ovarian cancer, prostate cancer, leukemia and colon cancer. Also disclosed are methods of treating endometrial cancer or other epithelial cancers, comprising administering an adiponectin therapeutic agent.
Use Of Antagonists Of Ghrelin Or Ghrelin Receptor To Treat Intestinal Inflammation
Use Of Antagonists Of Ghrelin Or Ghrelin Receptor To Treat Intestinal Inflammation
US Patent:
2007002, Feb 1, 2007
Filed:
Mar 19, 2004
Appl. No.:
10/549688
Inventors:
Charalabos Pothoulakis - Waban MA, US
Christos Mantzoros - Watertown MA, US
Dezheng Zhao - Newton MA, US
Christos Mantzoros - Watertown MA, US
Dezheng Zhao - Newton MA, US
International Classification:
A61K 39/395, A61K 38/17, A61K 38/22
US Classification:
424145100, 514012000
Abstract:
Methods for treating intestinal inflammation or ghrelin-mediated inflammation by inhibiting the activity of ghrelin or its receptor are described. Also described are methods for identifying ghrelin antagonists and ghrelin receptor antagonists.
Methods Of Treating Intestinal Inflammation
Methods Of Treating Intestinal Inflammation
US Patent:
2004022, Nov 18, 2004
Filed:
Oct 17, 2003
Appl. No.:
10/688194
Inventors:
Charalabos Pothoulakis - Weban MA, US
Christos Mantzoros - Watertown MA, US
Christos Mantzoros - Watertown MA, US
Assignee:
Beth Israel Deaconess Medical Center, Inc.
International Classification:
A61K039/395, A61K038/17
US Classification:
514/012000, 424/143100
Abstract:
Methods for treating intestinal inflammation by inhibiting the activity of leptin or its receptor are described.